Patel Sanjiv (CIK 1816210) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-18). Recent activity: Sell RLAY (48,199 shares), Buy RLAY (3,056 shares), Sell RLAY (48,199 shares), Buy RLAY (994 shares), Sell RLAY (43,168 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Relay Therapeutics, Inc. (RLAY) | President and CEO | Sell | 48,199 | $979,886 |
| 2026-07-08 | Relay Therapeutics, Inc. (RLAY) | President and CEO | Buy | 3,056 | $21,239 |
| 2026-07-08 | Relay Therapeutics, Inc. (RLAY) | President and CEO | Sell | 48,199 | $943,736 |
| 2026-01-07 | Relay Therapeutics, Inc. (RLAY) | President and CEO | Buy | 994 | $2,972 |
| 2026-01-07 | Relay Therapeutics, Inc. (RLAY) | President and CEO | Sell | 43,168 | $337,574 |
| 2025-11-04 | Relay Therapeutics, Inc. (RLAY) | President and CEO | Sell | 62,073 | $434,511 |
| 2025-07-10 | Relay Therapeutics, Inc. (RLAY) | President and CEO | Sell | 42,740 | $152,582 |
| 2025-07-10 | Relay Therapeutics, Inc. (RLAY) | President and CEO | Sell | 18,639 | $66,541 |
| 2025-07-01 | Relay Therapeutics, Inc. (RLAY) | President and CEO | Buy | 5,000 | $14,700 |
| 2025-04-24 | Relay Therapeutics, Inc. (RLAY) | President and CEO | Sell | 42,769 | $127,024 |
| 2025-04-24 | Relay Therapeutics, Inc. (RLAY) | President and CEO | Sell | 18,653 | $55,399 |
Source: SEC Form 4 filings · as of 2026-08-18